75 research outputs found
Characterization of Alginate/Silver Nanobiocomposites Synthesized by Solution Plasma Process and Their Antimicrobial Properties
Solution plasma process (SPP) was adopted to prepare alginate/silver nanoparticle (AL/AgNP) biocomposites. The biocomposites were synthesized in solutions of varying concentrations of AgNO3 (1−5 mM) and alginate (0.1−0.3%, w/w) by discharging plasma for 7 min at 800 V with 30 kHz frequency using a pulsed unipolar power supply. The AL/AgNP emulsion was fabricated into 3D scaffolds by freeze drying and lyophilization and then stabilized by cross-linking via UV irradiation. UV-Vis spectroscopy of the biocomposites showed a characteristic absorbance at the maximum of 415–440 nm with increase in the intensity of the peaks as the concentration of AgNO3 increased. FE-SEM analysis showed that the 3D scaffolds had microporous structures with fine and uniform pores of 3–9 ± 2.0 μm in diameter. TEM analysis revealed that AgNPs in the biocomposites were in spherical shape with size range of 5–40±2.0 nm (AL0.3/Ag5) and well distributed in the matrix. The AL/AgNP biocomposites showed microbicidal activity against 9 human pathogens with MIC of 9.6–21 μg/mL for bacteria and 85–425 μg/mL for fungi. Almost all of the E. coli cells (99.8%) were killed by the treatment with 42.5 μg/mL of AgNPs at room temperature for 1 h
Plant-Mediated Synthesis of Silver Nanoparticles: Their Characteristic Properties and Therapeutic Applications
Lippia javanica: a cheap natural source for the synthesis of antibacterial silver nanocolloid
Factors Inhibiting the Education Specialists/Agents in Transferring Technology from Lab to Land in India
Production and assessment of microalgal liquid fertilizer for the enhanced growth of four crop plants
Biodiversity and molecular evolution of microalgae on different epiphytes and substrates
10.3923/pjbs.2012.813.820Pakistan Journal of Biological Sciences1517813-82
Plant extract mediated synthesis of silver and gold nanoparticles and its antibacterial activity against clinically isolated pathogens
- …
